Finance Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billionOctober 27, 20250 Swiss drugmaker Novartis on Sunday stated it agreed to accumulate U.S. biotech agency Avidity Biosciences for about $12 billion in…
Finance How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI ChipsOctober 28, 20240 (Bloomberg) — Occupying the highest three flooring of an unremarkable workplace constructing in northern Mumbai, there’s little to differentiate Shreya…
